|
Microclinics Help Keep Kenyan HIV Patients in Care
Activating Patients’ Existing Social Networks Reduces Stigma By Jeff Sheehy on May 18, 2015
A team led by researchers from UC San Francisco, Organic Health Response, and
Microclinic International is reporting results of a study that showed significant benefits
of microclinics – an innovative intervention that mobilized rural Kenyan HIV patients’
informal social networks to support their staying in care.
The results showed that microclinics cut in half the normal rate of disengagement from care,
which was defined as missing a clinic appointment by 90 days or more, when compared to the
control group, and reduced the perceived stigma of HIV by 25 percent within the larger
community.
“When HIV patients fall out of care, they lose access to their medications, and untreated
HIV patients will eventually develop AIDS. Keeping patients in care is not only a challenge
in resource limited settings, but even in the U.S. where the CDC estimates that only 40
percent of HIV patients are regularly engaged in care,” said the study's lead
author, Matthew D. Hickey, a graduating UCSF
medical student who will be starting residency in UCSF's internal medicine/primary care program at San
Francisco General Hospital and Trauma Center.
“Microclinics are a novel approach in solving this problem, he said, “in large part because they directly
and innovatively address the issue of stigma.”
The research is available starting May 12 online ahead of print in the Journal of Acquired Immune Deficiency Syndromes.
The intervention took place on Mfangano Island in Lake Victoria, which is surrounded by the countries
of Uganda, Kenya and Tanzania. The island has a population of about 21,000 living in small villages
of 500 to 1,500 people. Almost 30 percent of the population is HIV infected.
FACES (Family AIDS Care and Education Services), a joint program of UCSF and the Kenya Medical Research Institute, has
been supporting HIV care, treatment and prevention in western Kenya, including the island, in
collaboration with the Kenya Ministry of Health since 2004.
FACES researchers and clinicians partnered with Microclinic International and
the Organic Health Response to assess whether its social network model would help retain HIV patients
in care. The Microclinic Social Network Model works with individuals and communities to identify
existing social networks and use those to address wide spread and deadly diseases in communities.
The Organic Health Response coordinates a solar-powered community center on Mfangano Island
that served as the headquarters for this intervention.
“The rural communities on Mfangano Island where we are working have tremendous stores of social
capital. People help each other when an individual or family is in need. If someone gets sick or
injured, needs help farming or getting together the money for school fees, friends and family
pitch in to help. But, that often was not true when the need was due to HIV. For
example, a breadwinner became sick with AIDS and everyone knew what was going on, but no one
talked about it. He fell through the cracks of his social network, and without
support, he was lost to care and did not manage to take his medications
faithfully. Eventually, he died of AIDS,” said study co-lead
author, Charles R. Salmen, MD, MPhil, the founding director of Organic Health Response.
The intervention was introduced into one set of communities served by the Sena Health Center; other
similar neighboring communities in the clinic's catchment area served as controls. Patients on
antiretroviral medications were invited to form microclinic groups. These groups
included five to 15 family members, close friends or other members of the patients' social network,
regardless of HIV status. Pre-existing social groups such as churches, soccer teams and money
lending clubs were also invited to form microclinic groups and participate. Each microclinic
group was assigned a community health worker and a facilitator. All participants
received confidential HIV testing and counseling.
“Microclinics are not a traditional support group composed of people confronting a similar challenge,
many of whom may not know each other. Instead, microclinics use organic networks to drive
positive behavior. And since patients receive support from existing networks, support is
sustained,” said study co-author Daniel Zoughbie, MSc, DPhil, chief executive officer
of Microclinic International.
The participants attended 10 group-discussion sessions over five months. The sessions educated
participants about HIV prevention and treatment, promoted group support through discussions
about confidentiality and HIV status disclosure, encouraged group support to assist in
taking anti-HIV medications faithfully and making clinic appointments, and encouraged
participants to outreach to the community to promote HIV testing and clinic
enrollment. At the end of the intervention, participants were
invited to take part in voluntary group HIV testing.
“Previously, stigma blocked access to social support because patients didn't disclose. Microclinics
opened up discussion and became the catalyst for destigmatizing HIV. This led to access to
support within social networks. Friends and family supported patients in getting to clinic
appointments and, in turn, expected appointments to be kept. They supported patients'
taking medications as directed and expected patients to take them. Silence was replaced
by active support,” said Hickey.
“UNAIDS has set a goals aiming to have 90 percent of people with HIV in the world successfully
treated and retained in care by 2020. The microclinic intervention, which redefines the unit
of care from an individual to an individual and his/her social network, is a cost effective,
scalable initiative that could help governments meet their targets,” said study
co-author, Craig Cohen , MD, MPH, UCSF professor of obstetrics, gynecology and reproductive sciences.
Co-authors include Elvin Geng , MD,
MPH, Peter Bacchetti , PhD,
Cinthia Blat, MPH, Robert A. Tessler , MD, Monica Gandhi , MD, MPH,
and Starley Shade , PhD, MS from UC San Francisco; Betty Njoroge, MBChB, MPH and Elisabeth A. Bukusi, MBChB, M.Med, MPH, PhD, PGD from the Kenya Medical Research
Institute; Dan Omollo, BSc, Brian Mattah, Gor Bernard Ouma, Marcus R. Salmen, MD, from the Mfangano Island Research Group, Organic Health Response, Kenya; Kathyrn J. Fiorella, MPH, from UC Berkeley; and Harold Campbell, PhD, from Microclinic International.
Funding for the research was provided by Google Inc via the Tides Foundation, the Craigslist Foundation,
the Mulago Foundation, the Rise Up Foundation, Horace W. Goldsmith Foundation, the Segal Family
Foundation, the National Institute of Allergy and Infectious Diseases, the Doris Duke
Charitable Foundation, and the UCSF School of Medicine's Dean Research Fellowship.
UCSF researchers are affiliated with the AIDS Research Institute (ARI) at UCSF , which houses hundreds of scientists and dozens
of programs throughout UCSF and affiliated labs and institutions, making ARI one of the largest AIDS
research entities in the world. UCSF ranks #1 among medical schools in the U.S. for its AIDS
programs according to U.S. News & World Report , as it has every year since the category
was created in 2001.
UCSF, the nation's leading university exclusively focused on health, is dedicated to transforming
health worldwide through advanced biomedical research, graduate-level education in the life
sciences and health professions, and excellence in patient care. It includes top-ranked
graduate schools of dentistry, medicine, nursing and pharmacy; a graduate division
with world-renowned programs in the biological sciences, a preeminent biomedical
research enterprise and top-tier hospitals, UCSF Medical Center and UCSF Benioff Children's Hospitals.
UCSF is the nation's leading university exclusively focused on health. Now celebrating the
150th anniversary of its founding as a medical college, UCSF is dedicated to transforming health
worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. It includes
top-ranked graduate schools of dentistry, medicine, nursing and pharmacy; a graduate division with
world-renowned programs in the biological sciences, a preeminent biomedical research enterprise
and top-tier hospitals, UCSF Medical Center and UCSF Benioff Children's Hospitals.
CONTACT:
Jeff Sheehy
jsheehy@ari.ucsf.edu
415-597-8165
Source: University of California, San Francisco
http://www.ucsf.edu/news/2015/05/129461/microclinics-help-keep-kenyan-hiv-patients-care
"Reproduced with permission - University of California, San Francisco "
University of California, San Francisco
For more HIV and AIDS News visit...
Positively Positive - Living with HIV/AIDS:
HIV/AIDS News
|
